Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 10, Special Issue 12 (2021)

Effects of intraperitoneal bupivacaine and bupivacaine-dexmedetomidine for intra-operative and post-operative pain management in dogs

Author(s):
Saurav Debnath, Hitesh Bayan, Bedanga Konwar, Prava Mayengbam and Kalyan Sarma
Abstract:
Pain management is difficult in animals due to their inability to verbalize the discomfort and adequacy of treatment. The study was aimed to evaluate the use intraperitoneal bupivacaine and bupivacaine-dexmedetomidine for intra-operative and post-operative pain management in dogs. Eighteen clinical cases of dogs requiring laparotomy were randomly divided into three groups viz. Group-B, BD and N comprising of six dogs in each. The animals were premedicated with glycopyrrolate, meloxicam and diazepam. Anaesthetic induction and maintenance was done by using propofol. Intraperitoneally bupivacaine, bupivacaine-dexmedetomidine and normal saline were infused in the three groups. Time for sedation, quality of sedation, time for induction, quality of induction, depth of anaesthesia, recovery time, quality of recovery and intra-operative analgesia, post-operative analgesia, heart rate, rectal temperature, respiratory rate and blood pressure were recorded. Intraperitoneal infusion of bupivacaine and bupivacaine-dexmedetomidine combination improved the intraoperative and postoperative analgesia. Clinical and cardiorespiratory changes following intraperitoneal bupivacaine and bupivacaine-dexmedetomidine combination were within physiological range.
Pages: 2019-2022  |  346 Views  105 Downloads
How to cite this article:
Saurav Debnath, Hitesh Bayan, Bedanga Konwar, Prava Mayengbam and Kalyan Sarma. Effects of intraperitoneal bupivacaine and bupivacaine-dexmedetomidine for intra-operative and post-operative pain management in dogs. The Pharma Innovation Journal. 2021; 10(12S): 2019-2022.

Call for book chapter